| A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies (NCT04227847) | Seagen, a wholly owned subsidiary of Pfizer | 2020-08-07 |
| Single and Multiple Ascending Dose Study of AMG 133 in Participants With Obesity (NCT04478708) | Amgen | 2020-08-07 |
| IMP4297 in Combination With Temozolomide in Patients With Advanced Solid Tumors and Small Cell Lung Cancer (NCT04434482) | Impact Therapeutics, Inc. | 2020-08-07 |
| A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types (NCT04300556) | Eisai Inc. | 2020-08-06 |
| A Study of the Effects of Multiple Doses of LY3372689 on the Brain in Healthy Participants (NCT04392271) | Eli Lilly and Company | 2020-08-06 |
| Safety and Pharmacokinetics of DWJ1439, DWJ1464, DWC202003 or DWC202004 in Healthy Volunteers (NCT04477369) | Daewoong Pharmaceutical Co. LTD. | 2020-08-06 |
| Investigation Of Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Single Doses Of Vupanorsen In Japanese Healthy Adult Participants With Elevated Triglycerides (NCT04459767) | Pfizer | 2020-08-06 |
| Safety and Feasibility of PD-1 Blockade in the Treatment of dMMR or MSI-H Rectal Cancer (NCT04357587) | Case Comprehensive Cancer Center | 2020-08-06 |
| A Study of TJ003234 in Rheumatoid Arthritis Patients (NCT04457856) | I-Mab Biopharma US Limited | 2020-08-06 |
| Type I Interferon Alfa-2a in Postmastectomy Breast Reconstruction (NCT04522557) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2020-08-06 |
| A Clinical Study of Melphalan Flufenamide (Melflufen) and Dexamethasone for Patients With Immunoglobulin Light Chain (AL) Amyloidosis (NCT04115956) | Oncopeptides AB | 2020-08-06 |
| Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy (NCT04430192) | Peter MacCallum Cancer Centre, Australia | 2020-08-06 |
| Clinical Trial of Naoqingzhiming Tablets in Healthy Chinese Subjects (NCT04902534) | The Affiliated Hospital of Qingdao University | 2020-08-05 |
| Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma (NCT04477200) | University of Michigan Rogel Cancer Center | 2020-08-05 |
| Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19 (NCT04550325) | Kamada, Ltd. | 2020-08-05 |
| Study of Mechanism of Action of Ligelizumab (QGE031) in Patients With Chronic Urticaria (NCT04513548) | Novartis Pharmaceuticals | 2020-08-05 |
| A Trial to Learn How a New Liquid Form of BAY1817080 is Tolerated and Taken up by the Body of Healthy Male Participants (Part A). By Labeling BAY1817080 With a Radioactive Substance (Carbon 14) Researchers Want to Learn How the Study Drug is Processed and Excreted by the Body After Dosing (Part B) (NCT04487431) | Bayer | 2020-08-05 |
| Clinical Trial of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris) (NCT04563533) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2020-08-05 |
| Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With COVID-19 (NCT05501418) | Ever Supreme Bio Technology Co., Ltd. | 2020-08-05 |
| A Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell Carcinoma (NCT04522323) | MedImmune LLC | 2020-08-05 |
| Use of Angiotensin-(1-7) in COVID-19 (NCT04633772) | Erasme University Hospital | 2020-08-05 |
| A Safety and Efficacy Study of CC-90009 Combinations in Subjects With Acute Myeloid Leukemia (NCT04336982) | Celgene | 2020-08-05 |
| Vitamin D as a Therapeutic Adjunct in the Stimulant Treatment of ADHD: a Proof-of-concept Tele-health Study of Stimulant-induced Improvement in Neurocognitive Functioning. (NCT04386811) | Yale University | 2020-08-05 |
| Pharmacokinetics, Pharmacodynamics and Safety of SHR4640 in Patients With Hepatic Impairment (NCT04305392) | Jiangsu HengRui Medicine Co., Ltd. | 2020-08-04 |
| A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies (NCT04440943) | Celldex Therapeutics | 2020-08-04 |
| Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of H&N (NCT04323202) | Case Comprehensive Cancer Center | 2020-08-04 |
| Multiple Ascending Dose Study of MEDI1341 in Patients With Parkinson's Disease (NCT04449484) | AstraZeneca | 2020-08-04 |
| Pharmacokinetic Characteristics, Safety, Tolerability and Immunogenicity of LY01008 and Avastin in Healthy Chinese Male Subjects (NCT05110118) | Shandong Boan Biotechnology Co., Ltd | 2020-08-04 |
| A Study in Children and Young People With Migraine to Learn What the Body Does to Eptinezumab (NCT04537429) | H. Lundbeck A/S | 2020-08-04 |
| Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects (NCT04480957) | Arcturus Therapeutics, Inc. | 2020-08-04 |
| Dosimetry Guided PRRT With 177Lu-DOTATATE in Children and Adolescents (NCT03923257) | Sue O'Dorisio | 2020-08-04 |
| A Trial of SHR-1703 in Healthy Adults (NCT04480762) | Jiangsu HengRui Medicine Co., Ltd. | 2020-08-04 |
| A Phase 1 Study of SH1573 Capsules in Subjects With Refractory or Relapsed Acute Myelogenous Leukemia (NCT04806659) | Nanjing Sanhome Pharmaceutical, Co., Ltd. | 2020-08-04 |
| A Study to Evaluate YH003 in Combination With Toripalimab (Anti-PD-1 mAb) in Subjects With Advanced Solid Tumors (NCT04481009) | Eucure (Beijing) Biopharma Co., Ltd | 2020-08-04 |
| Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy Subjects (NCT04473417) | Dong-A ST Co., Ltd. | 2020-08-04 |
| Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation (NCT04397796) | ImmunityBio, Inc. | 2020-08-03 |
| Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer (NCT04428203) | Zin W Myint | 2020-08-03 |
| A Study to Find the Best Dose of BI 1387446 Alone or in Combination With Ezabenlimab (BI 754091) in Patients With Different Types of Advanced or Metastatic Cancer (Solid Tumors) (NCT04147234) | Boehringer Ingelheim | 2020-08-03 |
| Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma (NCT04157127) | Diakonos Oncology Corporation | 2020-08-03 |
| Treatment of Chronic Medium-severe Periodontitis With Mesenchymal Stem Cells Predifferentiated in Osteogenic Direction (NCT04446897) | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 2020-08-03 |
| Dengue 3 Human Infection Model (DENV-3) (NCT04298138) | State University of New York - Upstate Medical University | 2020-08-03 |
| SAD and MAD Study With IV and SC Doses of ARGX-117 (NCT04532125) | argenx | 2020-08-03 |
| Study of the Combination of Binimetinib and Encorafenib in Adolescent Patients With Unresectable or Metastatic BRAF V600-mutant Melanoma (NCT03878719) | Pfizer | 2020-08-03 |
| A Trial to Compare BioChaperone Insulin Lispro Formulations With US Approved Humalog® and With EU Approved Humalog® in Patients With Type 1 Diabetes Mellitus (NCT04501107) | Adocia | 2020-08-03 |
| Evaluation of Drug Interaction Between HS-10234 and Emtriccitabine (NCT04477096) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2020-08-03 |
| A Single Ascending and Repeated Dose Study of Oral ZF874 in Healthy Volunteers and PiXZ Subjects (NCT04443192) | Z Factor Limited | 2020-08-03 |
| A Study of C-CAR039 Treatment in Subjects With r/r NHL Subjects Non-Hodgkin's Lymphoma (NCT04693676) | First Affiliated Hospital of Zhejiang University | 2020-08-03 |
| Study of a Single Subcutaneous Dose of Pozelimab Produced From Two Different Manufacturing Processes in Healthy Adult Participants (NCT04491838) | Regeneron Pharmaceuticals | 2020-08-03 |
| Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV (NCT04353778) | Icahn School of Medicine at Mount Sinai | 2020-08-03 |
| Mesenchymal Stem Cell Therapy (MSCs) and Conditioned Medium Therapy for Osteoartrithis (NCT04314661) | PT. Prodia Stem Cell Indonesia | 2020-08-03 |
| Open-label Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of a Single Oral Dose of [14C]-20 mg/100 μCi Anaprazole Sodium Enteric-coated Capsule in Healthy Adult Male Subjects (NCT04476394) | Sihuan Pharmaceutical Holdings Group Ltd. | 2020-08-03 |
| Study to Compare PK and Safety of Subcutaneous Injection of Ustekinumab and CT-P43 in Healthy Subjects (NCT04428814) | Celltrion | 2020-08-03 |
| Comparative Bioavailability Study Between Etoricoxib and Tramadol, Administered Individually or in Combination (NCT05533073) | Laboratorios Silanes S.A. de C.V. | 2020-08-03 |
| Vaccine Responsiveness After CAR-T Cell Therapy (NCT04410900) | Fred Hutchinson Cancer Center | 2020-08-03 |
| Study to Assess the Effect of Branebrutinib on the Drug Levels of Rosuvastatin in Healthy Participants (NCT04515628) | Bristol-Myers Squibb | 2020-08-02 |
| Clinical Bioequivalence Study on Two Metoprolol Tablet 100mg Formulations (NCT03082352) | Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited | 2020-08-01 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of SYHA1402 in Healthy Subjects (NCT04453618) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2020-08-01 |
| Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring Oxygen (NCT04502069) | RedHill Biopharma Limited | 2020-08-01 |
| Phase I/II Trial of Povidone-iodine (PVP-I) Nasal Swab For Preventing COVID-19 Spread in Healthy Subjects (NCT04510402) | Brigham and Women's Hospital | 2020-08-01 |
| Combinatorial Therapy to Induce an HIV Remission (NCT04357821) | University of California, San Francisco | 2020-08-01 |
| Pembrolizumab, Ibrutinib and Rituximab in PCNSL (NCT04421560) | Dana-Farber Cancer Institute | 2020-08-01 |
| A Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Protein BG505 SOSIP.GT1.1 Gp140 Vaccine, Adjuvanted in Healthy, HIV-uninfected Adults (NCT04224701) | International AIDS Vaccine Initiative | 2020-08-01 |
| Evaluation of Pharmacokinetics and Safety of AJU-A51 in Healthy Adults (NCT04972539) | AJU Pharm Co., Ltd. | 2020-08-01 |
| Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 2) (NCT04510818) | Ruijin Hospital | 2020-08-01 |
| Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 Infected Patients (NCT04371822) | Kafrelsheikh University | 2020-08-01 |
| Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors (NCT04106492) | Shasqi, Inc. | 2020-08-01 |
| To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19 (NCT04524052) | Daewoong Pharmaceutical Co. LTD. | 2020-08-01 |
| A Study of HNC042 in Healthy Chinese Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics (NCT04603989) | Guangzhou Henovcom Bioscience Co. Ltd. | 2020-08-01 |
| Allocetra-OTS in COVID-19 (NCT04513470) | Hadassah Medical Organization | 2020-08-01 |
| Abatacept for Patients With COVID-19 and Respiratory Distress (NCT04477642) | Beth Israel Deaconess Medical Center | 2020-08-01 |
| The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma (NCT04979611) | First Affiliated Hospital of Fujian Medical University | 2020-08-01 |
| Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 1) (NCT04508686) | Ruijin Hospital | 2020-08-01 |
| Evaluation of Safety, Biodistibution and Sensitivity/Specificity of PET/CT Imaging With 89Zr-TLX250 in Subjects With RCC (NCT04496089) | Telix Pharmaceuticals (Innovations) Pty Limited | 2020-08-01 |
| Mesenchymal Stem Cells in Patients Diagnosed With COVID-19 (NCT04611256) | Hospital Reg. Lic. Adolfo Lopez Mateos | 2020-08-01 |
| A Pharmacokinetic Study of JKB-122 Tablets Compared to Capsule (NCT04313205) | TaiwanJ Pharmaceuticals Co., Ltd | 2020-08-01 |
| Prevention of Acute Pancreatitis After Endoscopic Interventions (NCT04608760) | Vitebsk State Medical University | 2020-08-01 |
| Treatment of Urinary Incontinence in Men After Prostatectomy With Autologous Adipose-derived Mesenchymal Stem Cells (NCT04426643) | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 2020-08-01 |
| Effect of Zilretta Injection (NCT04261049) | University of North Carolina, Chapel Hill | 2020-08-01 |
| Novel CAR-T Cell Therapy in the Treatment of Hematopoietic and Lymphoid Malignancies (NCT05513612) | Shanghai Pudong Hospital | 2020-08-01 |
| Euphorbia Kansui and HIV/AIDS Functional Cure (NCT04503928) | Shanghai Public Health Clinical Center | 2020-08-01 |
| Mesenchymal Stem Cells for Radiation-induced Xerostomia (NCT03876197) | Rigshospitalet, Denmark | 2020-08-01 |
| Tele-health Enabled Clinical Trial for COVID-19 (NCT04489628) | University Hospitals Cleveland Medical Center | 2020-08-01 |
| Pilot Study of the Safety and Efficacy of Sulfasalazine in Pulmonary Arterial Hypertension (NCT04528056) | RenJi Hospital | 2020-08-01 |
| Efficacy of Intensified Transcranial Direct Current Stimulation in Obsessive-compulsive Disorder (NCT05501132) | The National Brain Mapping Laboratory (NBML) | 2020-08-01 |
| Tc99m-MAA Bronchial Artery Injection During Bronchial Embolization for Pulmonary Mass Induced Hemoptysis for Dosimetry Planning (NCT04105283) | Massachusetts General Hospital | 2020-08-01 |
| Anti-PD-L1 Armored Anti-CD22 CAR-T/CAR-TILs Targeting Patients With Solid Tumors (NCT04556669) | Hebei Senlang Biotechnology Inc., Ltd. | 2020-08-01 |
| Covid-19 Convalescent Plasma as Prevention and Treatment for Children With Underlying Medical Conditions (NCT04462848) | University of California, Los Angeles | 2020-08-01 |
| Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Canada (NCT04398147) | CanSino Biologics Inc. | 2020-08-01 |
| Safety and Efficacy of IBI322 in Chinese Subjects With Advanced Malignant Tumors (NCT04328831) | Innovent Biologics (Suzhou) Co. Ltd. | 2020-07-31 |
| A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory T or B Cell Malignancies (COBALT-LYM) (NCT04502446) | CRISPR Therapeutics AG | 2020-07-31 |
| GSK3739937 First-Time-In-Human (FTIH) Study in Healthy Volunteers (NCT04493684) | ViiV Healthcare | 2020-07-31 |
| Multiple Ascending Dose Study of CTI-1601 Versus Placebo in Subjects With Friedreich's Ataxia (NCT04519567) | Larimar Therapeutics, Inc. | 2020-07-31 |
| Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of Cabotegravir (CAB) 400 Milligrams Per Milliliter (mg/mL) Formulation in Healthy Adult Participants (NCT04484337) | ViiV Healthcare | 2020-07-31 |
| A Study of Ramucirumab (LY3009806) in Healthy Participants (NCT04495478) | Eli Lilly and Company | 2020-07-30 |
| Phase I Study in Advanced Malignancies With 5-ALA (NCT04381806) | Fox Chase Cancer Center | 2020-07-30 |
| Study of ARO-ENaC in Healthy Volunteers and in Patients With Cystic Fibrosis (NCT04375514) | Arrowhead Pharmaceuticals | 2020-07-30 |
| First-In-Human Dose-Escalation Study of STP1002 in Patients With Advanced-Stage Solid Tumors (NCT04505839) | ST Pharm Co., Ltd. | 2020-07-30 |
| Neoadjuvant Toripalimab and Paclitaxel/Cisplatin on Pathological Response in Oral Squamous Cell Carcinoma Patients (NCT04473716) | Shanghai Jiao Tong University School of Medicine | 2020-07-30 |
| A Study to Assess the Effect of Multiple Doses of AZD5718 on Pharmacokinetics of Oral Midazolam in Healthy Subjects (NCT04492709) | AstraZeneca | 2020-07-30 |
| A Food-Effect Study of AND017 in Healthy Participants (NCT04712500) | Kind Pharmaceuticals LLC | 2020-07-30 |